Hikal

Market Cap (₹ Cr.)

₹4,836

52 Week High

416.95

Book Value

₹96

52 Week Low

260.30

PE Ratio

65.81

PB Ratio

4.02

PE for Sector

37.14

PB for Sector

4.89

ROE

6.92 %

ROCE

8.78 %

Dividend Yield

0.31 %

EPS

₹5.49

Industry

Pharmaceuticals

Sector

Pharmaceuticals - Indian - Bulk Drugs

Investment Returns

In Long Term

In Short Term

1 Year

0.00%

2 Years

0.00%

3 Years

0.00%

4 Years

0.00%

5 Years

0.00%

Growth Rate

Revenue Growth

-11.90 %

Net Income Growth

-11.20 %

Cash Flow Change

-40.78 %

ROE

-15.25 %

ROCE

-5.86 %

EBITDA Margin (Avg.)

16.53 %

Financial Results

Quarterly Financials	Mar 2015	Jun 2015	Sept 2015	Dec 2015	Mar 2016	Jun 2016	Sept 2016	Dec 2016	Mar 2017	Jun 2017	Sept 2017	Dec 2017	Mar 2018	Jun 2018	Sept 2018	Dec 2018	Mar 2019	Jun 2019	Sept 2019	Dec 2019	Mar 2020	Jun 2020	Sept 2020	Dec 2020	Mar 2021	Jun 2021	Sept 2021	Dec 2021	Mar 2022	Jun 2022	Sept 2022	Dec 2022	Mar 2023	Jun 2023	Sept 2023	Dec 2023	Mar 2024	Jun 2024	Sept 2024
Revenue	214	192	204	241	290	222	233	251	311	264	293	352	392	327	395	412	458	404	322	405	381	353	373	464	535	460	470	515	503	382	560	543	546	389	436	448	515	407	453
Expenses	168	155	165	194	230	178	185	203	251	213	239	284	319	265	320	333	374	335	278	328	308	300	302	372	423	361	378	422	441	356	489	466	457	338	377	383	420	349	378
EBITDA	45	37	39	47	60	45	48	49	59	51	54	68	73	62	76	79	84	69	44	76	72	53	71	92	112	99	92	93	61	26	71	77	88	51	59	65	95	59	75
Operating Profit %	21 %	19 %	19 %	19 %	21 %	20 %	19 %	18 %	18 %	18 %	17 %	18 %	17 %	18 %	18 %	18 %	17 %	16 %	7 %	16 %	18 %	14 %	18 %	19 %	20 %	21 %	18 %	17 %	12 %	4 %	12 %	14 %	15 %	13 %	12 %	13 %	18 %	14 %	16 %
Depreciation	18	16	17	17	17	18	17	17	17	21	21	21	21	23	24	24	23	20	21	21	21	21	21	22	22	23	24	25	24	27	27	28	27	28	29	29	32	32	32
Interest	9	18	17	14	13	13	11	14	10	12	13	12	12	16	16	13	13	12	14	13	14	10	9	8	10	8	8	7	8	11	11	13	13	14	13	14	15	20	19
Profit Before Tax	18	3	6	16	29	14	20	18	32	18	20	34	39	23	36	42	48	37	10	42	38	23	41	62	81	68	60	62	29	-12	33	36	49	10	17	22	47	7	25
Tax	9	1	1	4	5	4	5	6	-2	6	7	13	19	8	12	13	12	12	1	13	9	8	15	23	34	19	16	17	8	0	5	10	15	3	5	5	16	2	7
Net Profit	10	2	5	12	22	12	16	14	29	13	15	23	25	16	24	29	33	25	6	28	24	15	27	40	51	51	44	45	21	-9	25	26	36	7	13	16	34	5	18
EPS in ₹	1.24	0.22	0.59	1.51	2.71	1.39	1.97	1.67	3.51	1.60	1.23	2.81	3.08	1.29	1.98	2.38	2.70	2.05	0.52	2.30	1.98	1.22	2.18	3.27	4.13	4.10	3.57	3.67	1.68	-0.73	2.01	2.14	2.93	0.56	1.02	1.32	2.75	0.42	1.47

Show % Change

Above figures are in Rs. Crores

Balance Sheet

Balance Sheet	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	1,293	1,276	1,379	1,542	1,686	1,768	1,913	2,213	2,385	2,487
Fixed Assets	639	623	668	634	713	735	713	879	948	1,071
Current Assets	501	467	577	690	830	775	879	964	939	967
Capital Work in Progress	62	66	63	118	79	161	254	295	412	414
Investments	0	0	4	3	1	1	1	11	5	5
Other Assets	592	587	645	788	893	871	946	1,028	1,020	997
Total Liabilities	759	711	774	872	929	951	980	1,145	1,252	1,299
Current Liabilities	518	374	440	560	603	596	657	769	662	757
Non Current Liabilities	242	337	334	312	327	355	323	376	590	543
Total Equity	533	565	605	669	756	817	933	1,068	1,133	1,188
Reserve & Surplus	517	548	589	653	732	792	909	1,043	1,109	1,163
Share Capital	16	16	16	16	25	25	25	25	25	25

Show % Change

Above figures are in Rs. Crores

Cash Flow

Cash Flow	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Cash Flow	-10	-2	-2	4	6	20	-24	4	15	-14
Investing Activities	-43	-64	-103	-110	-125	-164	-156	-284	-292	-174
Operating Activities	102	186	163	139	186	285	229	294	315	187
Financing Activities	-69	-124	-63	-25	-55	-101	-97	-6	-8	-27

Show % Change

Above figures are in Rs. Crores

Share Holding

% Holding	Mar 2021	Jun 2021	Sept 2021	Dec 2021	Mar 2022	Jun 2022	Sept 2022	Dec 2022	Mar 2023	Jun 2023	Sept 2023	Dec 2023	Mar 2024	Jun 2024	Sept 2024
Promoter	68.77 %	68.77 %	68.77 %	68.77 %	68.77 %	68.77 %	68.77 %	68.83 %	68.85 %	68.85 %	68.85 %	68.85 %	68.85 %	68.85 %	68.85 %
FIIs	5.91 %	4.20 %	6.36 %	6.91 %	6.92 %	3.91 %	4.27 %	4.40 %	4.56 %	4.56 %	4.81 %	6.13 %	6.55 %	6.67 %	6.78 %
DIIs	0.59 %	0.70 %	0.59 %	0.38 %	0.88 %	0.89 %	1.37 %	1.57 %	2.19 %	2.78 %	3.12 %	3.15 %	3.53 %	3.17 %	3.58 %
Government	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %
Public / Retail	24.73 %	26.33 %	24.28 %	23.93 %	23.42 %	26.43 %	25.59 %	25.21 %	24.40 %	23.80 %	23.22 %	21.86 %	21.07 %	21.32 %	20.79 %

Show % Change

Dividend History

Peer Comparison Compare Peers on Screener

Competitors	LTP	Market Cap (₹ Cr.)	P/E Ratio	Revenue (₹ Cr.)	YoY Revenue Growth %	Net Profit (₹ Cr.)	YoY Profit Growth %	RSI
Sun Pharmaceutical	1,774.00	4,25,929.94	38.00	49,887.17	12.06	9,648	27.35	40.28
Divis Laboratories	5,886.70	1,56,524.27	85.25	8,184.00	0.89	1,600	46.55	56.39
Cipla	1,470.00	1,18,825.56	25.74	26,520.66	14.17	4,155	12.95	38.47
Mankind Pharma	2,567.05	1,02,885.42	48.65	10,615.63	19.57	1,942	28.89	46.80
Dr Reddys Laboratories	1,213.40	1,01,290.13	18.97	28,905.40	12.36	5,578	-9.47	32.64
Zydus Life Science	947.95	95,280.30	22.27	19,831.50	13.82	3,831	14.57	32.02
Lupin	2,029.55	92,929.19	35.38	20,141.50	19.94	1,936	73.52	37.01
Aurobindo Pharma	1,246.00	73,119.28	20.05	29,559.25	17.55	3,169	8.65	20.74
Alkem Laboratories	5,534.00	66,062.65	30.38	12,978.42	9.84	1,811	14.16	35.74
Glenmark Pharmaceuticals	1,491.30	42,112.35	-	12,653.09	6.58	-1,831	675.84	30.08